Chapman: GI Alliance observes Gastroparesis Awareness Month

By J. Casey Chapman, M.D., Chief Medical Officer, GI Alliance

As a gastroenterologist at GI Alliance, I am deeply committed to raising awareness about gastroparesis, a chronic digestive disorder that affects 1 in 4 Americans. This August, during Gastroparesis Awareness Month, I hope to shed light on this condition and its connection to medications like Ozempic, which have recently been linked to gastroparesis symptoms.

Understanding Gastroparesis

Gastroparesis, also known as delayed gastric emptying, is a disorder that impairs the stomach’s ability to move food to the small intestine. Patients with gastroparesis experience a range of debilitating symptoms, including chronic nausea, vomiting, bloating, abdominal pain, and a feeling of fullness after eating even small amounts of food. The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) indicates that the causes of gastroparesis are often unknown. However, it is frequently associated with diabetes, infections, certain medications, and surgeries that impact the stomach muscles.

Ozempic and Gastroparesis

There have been reports linking the use of Ozempic (semaglutide), a member of the GLP-1 receptor agonist(GLP-1RA), to an increased risk of developing gastroparesis. One of the GLP-1RA’s actions is to delay gastric emptying and regulate blood sugar levels. Ozempic is widely used to manage type 2 diabetes and has recently gained popularity as a weight loss medication. In patients who have gastroparesis or risk factors for developing gastroparesis it may worsen or potentiate the symptoms. Healthline and other news outlets have highlighted that some patients on Ozempic have reported symptoms consistent with gastroparesis. This association underscores the importance of being aware of potential side effects and recognizing early symptoms.

GI Alliance’s Commitment During Gastroparesis Awareness Month

At GI Alliance, we are dedicated to educating the public, supporting patients, and advancing research on gastroparesis. Understanding the different types of gastroparesis is crucial:

• Diabetes-related gastroparesis: This type is linked to long-term diabetes management.
• Post-surgical gastroparesis: This occurs after surgeries that affect the stomach muscles.
• Idiopathic gastroparesis: This form occurs without an identifiable reason.

The common symptoms of gastroparesis include a consistent bloated feeling, feeling full quickly and for long periods, indigestion, nausea, vomiting, regurgitating undigested food, constipation, blood sugar issues, loss of appetite, acid reflux, and heartburn.

Research and Advocacy

GI Alliance is steadfast in its support and advocacy for research into gastroparesis, with the goal of discovering better treatment options and ultimately a cure. We also emphasize the importance of safer medication practices and heightened awareness of potential medication side effects.

I encourage everyone to join us at GI Alliance in observing Gastroparesis Awareness Month. By increasing awareness and understanding, we can significantly impact the lives of those affected by this condition. For more information and resources, please visit our website at GI Alliance.

At GI Alliance, we are the leading physician-led gastroenterology practice in the United States, dedicated to providing comprehensive digestive health services. Our team of experienced gastroenterologists is committed to delivering patient-centered care, advancing innovative treatments, and improving the quality of life for our patients.

Together, let’s raise awareness, promote understanding, and support those living with gastroparesis this August.

For more information, visit gialliance.com.